David Baskin
President at Baskin Wealth Management
Member since: Feb '01 · 4841 Opinions
Rating Card
Premium content| All | 
Rating
| 
Big Win
| 
Win
| 
Neutral
| 
Loss
| 
Big Loss
|  |
|---|---|---|---|---|---|---|---|
| 4.14 | 117 23.03% | 142 27.95% | 94 18.50% | 104 20.47% | 51 10.04% | ||
| 1 Month | 3.82 | 3 2.75% | 36 33.03% | 41 37.61% | 27 24.77% | 2 1.83% | |
| 6 Months | 4.14 | 12 11.01% | 43 39.45% | 16 14.68% | 28 25.69% | 10 9.17% | |
| 12 Months | 4.23 | 24 22.02% | 31 28.44% | 20 18.35% | 26 23.85% | 8 7.34% | |
| 2 Years | 4.36 | 42 40.78% | 22 21.36% | 12 11.65% | 15 14.56% | 12 11.65% | |
| 5 Years | 4.14 | 36 46.15% | 10 12.82% | 5 6.41% | 8 10.26% | 19 24.36% |
Stock Opinions by David Baskin
We might have recession in Canada, not the US. The Bank of Canada has gone too far. Canadians are too indebted and too many have variable rate mortgages. So consumers will spend less. It will be a mild recession. Canada imports so much food and doesn't control energy costs, so we can't control that much inflation. But savers will do well, given these high rates. Seniors, who rely on fixed income, will collect 5% interest. The US will pull off a soft landing.
The largest company in Scandinavia. There is and will be lots of competition in weight-loss drugs. NVO has made a fortune through this drug, but their margins will shrink over time as competitors come. If you own this already, take profits, but don't expect NVO to double again.
It went ex-dividend today so shares declined and will rise until the next dividend date. This shouldn't determine whether you buy a stock or not. It yields near 8%. Some don't like their heavy debt and prefer collecting a safe 6% bond. But once bonds pay lower, like 4%, then shares like this pop up and ENB will hit $50 in a heartbeat.
Unfortunately, Brookfield is looking like the old Brascan empire, a plate of spaghetti, where they spin off all these entities, then buy them back and it's hard to keep track of how many there are. That said, BAM and BN-T are grossly undervalued. The market is overreacting to the impact of commercial real estate BN-T, in particular. Do the swap.
Unfortunately, Brookfield is looking like the old Brascan empire, a plate of spaghetti, where they spin off all these entities, then buy them back and it's hard to keep track of how many there are. That said, BAM and BN-T are grossly undervalued. The market is overreacting to the impact of commercial real estate BN-T, in particular.
Unfortunately, Brookfield is looking like the old Brascan empire, a plate of spaghetti, where they spin off all these entities, then buy them back and it's hard to keep track of how many there are. That said, BAM and BN-T are grossly undervalued. The market is overreacting to the impact of commercial real estate BN-T, in particular.
